Exit Text Mode

Skip nav

  • Home
  • Macular Disease
    • Macular Degeneration
      • About Macular Degeneration
      • Check My Macula
      • What Happens?
      • Risk Factors
      • Prevention
      • Detection
      • Diagnosis
      • Treatment
      • Charles Bonnet Syndrome
      • Cataracts and Macular Degeneration
      • Frequently Asked Questions
    • Diabetic Retinopathy
      • About Diabetic Retinopathy
      • About Diabetes
      • What Happens?
      • Risk Factors
      • Prevention
      • Detection
      • Diagnosis
      • Treatment
      • Frequently Asked Questions
    • Low Vision
      • Living with Low Vision
      • Carer and Family
      • Aids and Technology
      • Slips, Trips and Falls
      • Legal blindness
    • Other Macular Diseases
      • Best Disease
      • Macular Hole
      • Macular Pucker
      • Macular Telangiectasia
      • Myopic Macular Degeneration
      • Retinal Detachment
      • Retinitis Pigmentosa
      • Retinal Vein Occlusion
      • Stargardt Disease
      • Central Serous Chorioretinopathy (CSC)
      • Posterior Vitreous Detachment and Floaters
      • Vitreomacular Traction Syndrome
    • Visit Eye Health Professional
      • Eye Injection Costs and Rebates
    • Macular Disease
      • Anti-VEGF injections for macular disease
  • Research
    • Research Grants Program
      • Research Grants Awarded
      • Research Grant Recipients
      • Apply for the MDFA Research Grants Program
      • Research Grants Panel
    • Support Research
    • Latest Research
      • Research News
      • MDFA Research
      • Macular Diseases
      • Understanding Research
      • Social Impact
    • Research Updates
      • Annual Research Update
      • Weekly Research Updates for Professionals
    • Research studies
  • Resources
    • Order Publications and Resources
    • Find a Healthcare Provider
    • Audio and Video
      • Audio
      • Podcasts
      • Patient Voices
      • Videos
    • Macula Menus
    • Check My Macula toolkits
    • Aged care resources
  • News & Events
    • Newsletters
      • Vision Voice Newsletters
      • Subscribe to Newsletters
      • Archive
    • News
      • 2021 news
      • 2020 news
      • 2019 News
      • 2018 News
      • 2017 News
      • 2016 News
      • Archived News
    • Events & Activities
      • Community Events
      • Education Sessions
      • Events Calendar
      • Watch past webinars
    • Media Centre
      • Media Releases
  • Foundation
    • Organisation
      • History
      • Objectives
      • Guiding Principles
      • Annual Reports
      • Whistleblower Policy
      • Financial Statements
    • People
      • Patron
      • State Patrons / Representatives
      • Ambassadors
      • Foundation Board
      • Committees
      • State Chairs
      • National Research Advisor
    • Our Work
      • Awareness
      • Education
      • Support Services
      • Research
      • Representation
    • Support Us
      • Donate
      • Bequests
      • Fundraise
      • Volunteer
      • Friends of the Foundation
      • Sponsors and Supporters
      • Professional Friends
    • Contact Us


  • About Macular Degeneration

    • Album
    • Gallery
    Macular degeneration is the leading cause of major vision loss in Australia.

    Macular degeneration, also known as age-related macular degeneration (AMD) is the name given to a group of chronic, degenerative retinal eye diseases that cause progressive loss of central vision, leaving the peripheral or side vision intact. It affects the ability to read, drive, recognise faces and perform activities that require detailed vision. Macular degeneration is the leading cause of legal blindness and severe vision loss in Australia, responsible for 50% of all cases of blindness.

    Macular degeneration is usually related to ageing and most frequently affects people over the age of 50. However, it is not a normal or inevitable consequence of ageing. 

    Macular degeneration is progressive and painless and does not result in total vision loss.

    Stages of macular degeneration

    Macular degeneration is classified as:

    Early and intermediate stage

    Caused by the progressive build-up of waste material (drusen) under the retina. These stages typically have little or no impact on vision, however some people with the intermediate stage may notice changes to their central vision. Currently there is no treatment available for the early and intermediate stages. Research is being conducted to develop treatments.

    Progression to late stage may occur, however progression in each eye can differ. Diet and lifestyle are important for maintaining healthy eyes. A select combination of vitamins and minerals may reduce the risk of progression in some individuals. Advice from an eye care professional should be sought.

    Late stage

    This is the vision impairing stage, which can be further divided into dry (atrophic) macular degeneration or wet (neovascular) macular degeneration.

    • Dry (atrophic): caused by the gradual atrophy (loss) of retinal cells. It may lead to a gradual loss of central vision. Currently there is no treatment available for the dry form. Research is being conducted to develop treatments. 
    • Wet (neovascular): caused by the formation of fragile blood vessels which leak fluid and blood within and under the retina. It often leads to a rapid loss of central vision. Loss of vision in one eye may go unnoticed if vision in the fellow eye is good. Regular vision testing of each eye in turn is recommended. 

    Early detection is critical

    The early detection of any form of macular degeneration is crucial to saving sight. Difficulty with vision should never be dismissed as just a part of getting older. In its early stages macular degeneration may not result in noticeable visual symptoms but it can be detected with an eye examination.

    The earlier that macular degeneration is detected the earlier that steps can be undertaken to help slow its progression and save sight through treatment and/or lifestyle modifications.

    Any sudden changes to vision should be treated as a medical emergency. See an optometrist or ophthalmologist immediately.

    Prevalence

    About one in seven Australians – or 1.29 million people – over the age of 50 years has some evidence of this disease. 

    Approximately 17% of these people (over 200,000) will experience vision impairment. Almost 15% of Australians over 80 years (around 160,000) have vision loss or blindness from age-related macular degeneration. 

     

    Return to the top of the page